IDEAS was for general company overview IMO so talking about the entire pipeline certainly justified.

ASCO, on the other hand, is STRICTLY for Kevetrin, and strictly for Cancer research matters.

I am sure in further private talks Prurisol may be discussed but only in private one on one conversations where the subject is broached to CTIX and not them bringing it up to the attendees.